Search Results

You are looking at 141 - 150 of 473 items for :

  • Refine by Access: All x
Clear All
Full access

Presenter: Ronald S. Go

medical history and complete physical examination], we recommend a PET/CT scan because many of the lesions appear fibrotic and are infiltrative in nature,” Dr. Go commented. If PET/CT is unavailable, a whole-body CT scan, MRI of the brain, and bone scan

Full access

NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020

Featured Updates to the NCCN Guidelines

Shaji K. Kumar, Natalie S. Callander, Jens Hillengass, Michaela Liedtke, Muhamed Baljevic, Erica Campagnaro, Jorge J. Castillo, Jason C. Chandler, Robert F. Cornell, Caitlin Costello, Yvonne Efebera, Matthew Faiman, Alfred Garfall, Kelly Godby, Leona Holmberg, Myo Htut, Carol Ann Huff, Yubin Kang, Ola Landgren, Ehsan Malek, Thomas Martin, James Omel, Noopur Raje, Douglas Sborov, Seema Singhal, Keith Stockerl-Goldstein, Carlyn Tan, Donna Weber, Alyse Johnson-Chilla, Jennifer Keller, and Rashmi Kumar

myeloma bone disease and stability of the spine. MRI is useful for discerning smoldering myeloma from MM. Because the disease burden in patients with smoldering myeloma is lower than in those with MM, imaging techniques with high sensitivity must be used

Full access

Jonathan R. Strosberg, Gary D. Hammer, and Gerard M. Doherty

Edited by Kerrin G. Robinson

. 22 Yun M Kim W Alnafisi N . 18 F-FDG PET in characterizing adrenal lesions detected on CT or MRI . J Nucl Med 2001 ; 42 : 1795 – 1799 . 23 Caoili EM Korobkin M Brown RK . Differentiating adrenal adenomas from nonadenomas using (18

Full access

Kenneth Offit

, noting that, in the case of PALB2, he anticipated that future studies may strengthen the ovarian cancer association. “Currently the American Cancer Society has suggested that lifetime risks be used to determine whether a patient should undergo MRI

Full access

Julian C. Hong, Matthew J. Boyer, Daphna Y. Spiegel, Christina D. Williams, Betty C. Tong, Scott L. Shofer, Michael J. Moravan, Michael J. Kelley, and Joseph K. Salama

therapy were classified as receiving platinum-based therapy. Patients documented in the VACCR as having undergone resection, surgery not otherwise specified, or tumor destruction were considered to have undergone surgery. Use of PET and brain MRI for

Full access

Wylie Burke and Nancy Press

screening with MRI—what are the data for patients at high risk? N Engl J Med 2004 ; 351 : 497 – 500 . 11. Nelson HD Huffman LH Fu R Harris EL . Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility

Full access

Nishant Patel, Adam C. Yopp, and Amit G. Singal

Most patients presented initially with an abnormal imaging study, with 219 (48%) presenting with abnormal abdominal ultrasound and 149 (33%) presenting with a mass on CT or MRI. AFP level was elevated in 135 patients (30%) including 67 whose

Full access

R. Lor Randall and William Gowski

. Philadelphia, PA : Lippincott-Raven ; 1996 . 17 Colyer RA Sallay P Buckwalter K . MRI assessment of chondroid matrix tumors . In: Limb Salvage: Current Trends–Proceedings of the 7th International Symposium. Singapore: International Symposium of

Full access

on disease stage and histology. All imaging procedures recommended in the NCCN Guidelines, including radiographs, CT scans, MRI, functional nuclear medicine imaging (PET, SPECT), and ultrasound, are included within NCCN Imaging AUC. NCCN Imaging AUC

Full access

brain MRI.” ➤ 7th bullet was added: “Baseline CRP and serum ferritin.” • Post-CAR T-Cell Infusion: ➤ 1st bullet was revised: “Hospitalization or extremely close outpatient monitoring at centers with transplant or prior outpatient CAR T